It has been confirmed that NAMPT is highly expressed in various malignant tumors such as breast cancer, prostate cancer, gastric cancer, thyroid cancer, colon cancer and hematological tumors.251 Therefore, NAMPT is considered as a drug target for antitumor therapy.252. This evidence concerns the gene NAMPT and thyroid gland carcinoma.